Exact Mass: 348.0547

Exact Mass Matches: 348.0547

Found 124 metabolites which its exact mass value is equals to given mass value 348.0547, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Inosine 5'-monophosphate (IMP)

{[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-6,9-dihydro-1H-purin-9-yl)oxolan-2-yl]methoxy}phosphonic acid

C10H13N4O8P (348.0471)


Inosinic acid, also known as inosine monophosphate, IMP, 5-inosinate or 5-IMP, belongs to the class of organic compounds known as purine ribonucleoside monophosphates. These are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. IMP is also classified as a nucleotide (a nucleoside monophosphate). Inosinic acid exists in all living species, ranging from bacteria to plants to humans. IMP is widely used as a flavor enhancer. In the food industry it is known as E number reference E630. Inosinic acid can be converted into various salts including disodium inosinate (E631), dipotassium inosinate (E632), and calcium inosinate (E633). These three inosinate compounds are used as flavor enhancers for the basic taste umami. These inosinate salts are mostly used in soups, sauces, and seasonings for the intensification and balance of the flavor of meat. Inosinic acid is typically obtained from chicken byproducts or other meat industry waste. Inosinic acid or IMP is important in metabolism. It is the ribonucleotide of hypoxanthine and the first nucleotide formed during the synthesis of purine nucleotides. It can also be formed by the deamination of adenosine monophosphate by AMP deaminase. GMP is formed by the inosinate oxidation to xanthylate (XMP). Within humans, inosinic acid participates in a number of enzymatic reactions. In particular, inosinic acid can be converted into phosphoribosyl formamidocarboxamide; which is catalyzed by the bifunctional purine biosynthesis protein. In addition, inosinic acid can be converted into xanthylic acid; which is catalyzed by the enzyme inosine-5-monophosphate dehydrogenase 1. Origin: Microbe; Formula(Parent): C10H13N4O8P; Bottle Name:Inosine-5-monophosphate; PRIME Parent Name:Inosine-5-monophosphate; PRIME in-house No.:0258, Purines A purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety. COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map Acquisition and generation of the data is financially supported in part by CREST/JST. relative retention time with respect to 9-anthracene Carboxylic Acid is 0.056 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.057 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Inosinic acid is an endogenous metabolite.

   

2-(alpha-D-Mannosyl)-3-phosphoglycerate

2-(α-D-Mannosyl)-3-phosphoglycerate

C9H17O12P (348.0458)


   

2-O-(6-Phospho-alpha-mannosyl)-D-glycerate

(2R)-3-hydroxy-2-{[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-[(phosphonooxy)methyl]oxan-2-yl]oxy}propanoic acid

C9H17O12P (348.0458)


2-O-(6-Phospho-alpha-mannosyl)-D-glycerate is an alpha-D-mannosylglycerate (MG) that is an intermediate in 2-O-alpha-mannosyl-D-glycerate degradation. It can be generated from 2-O-alpha-mannosyl-D-glycerate via the enzyme 2-O-alpha-mannosyl-D-glycerate transporting phosphotransferase system (mngA). 2-O-Alpha-mannosyl-D-glycerate is a natural extremolyte identified in microorganisms growing under extremely high temperatures up to 100 oC, and had been shown to protect proteins against various stress conditions such as heat, freezing, thawing, and drying. MG that is naturally occurring hyperthermophilic osmolytes, could be potential drug candidates or lead compounds against alpha,beta aggregation associated with Alzheimers disease(PMID: 18304694). In most organisms MG is produced from guanosine pyrophosphate mannose (GDP-alpha-D-mannose) via mannosyl-3-phosphoglycerate in two steps, catalyzed by the enzymes mannosyl-3-phosphoglycerate synthase and mannosyl-3-phosphoglycerate phosphatase. [HMDB] 2-O-(6-Phospho-alpha-mannosyl)-D-glycerate is an alpha-D-mannosylglycerate (MG) that is an intermediate in 2-O-alpha-mannosyl-D-glycerate degradation. It can be generated from 2-O-alpha-mannosyl-D-glycerate via the enzyme 2-O-alpha-mannosyl-D-glycerate transporting phosphotransferase system (mngA). 2-O-Alpha-mannosyl-D-glycerate is a natural extremolyte identified in microorganisms growing under extremely high temperatures up to 100 oC, and had been shown to protect proteins against various stress conditions such as heat, freezing, thawing, and drying. MG that is naturally occurring hyperthermophilic osmolytes, could be potential drug candidates or lead compounds against alpha,beta aggregation associated with Alzheimers disease(PMID: 18304694). In most organisms MG is produced from guanosine pyrophosphate mannose (GDP-alpha-D-mannose) via mannosyl-3-phosphoglycerate in two steps, catalyzed by the enzymes mannosyl-3-phosphoglycerate synthase and mannosyl-3-phosphoglycerate phosphatase.

   

2-keto-3-deoxy-D-glycero-D-galacto-nononate 9-phosphate

2-Keto-3-deoxy-D-glycero-D-galacto-nononate 9-phosphate; 3-Deoxy-D-glycero-D-galacto-non-2-ulosonate 9-phosphate; KDN 9-phosphate

C9H17O12P (348.0458)


   

(2R)-2-(alpha-D-glucopyranosyloxy)-3-(phosphonooxy)propanoic acid

(2R)-2-(alpha-D-glucopyranosyloxy)-3-(phosphonooxy)propanoic acid

C9H17O12P (348.0458)


   

Inosine 2'-phosphate

{[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-2-(6-oxo-6,9-dihydro-3H-purin-9-yl)oxolan-3-yl]oxy}phosphonic acid

C10H13N4O8P (348.0471)


Inosine 2-phosphate is an inosine nucleotide containing a pyrophosphate group esterified to C2 of the sugar moiety. Inosine 2-phosphate is a product of 2,3-cyclic-nucleotide 3-phosphodiesterase (EC 3.1.4.37). This enzyme (also called CNP) catalyzes the chemical reaction: nucleoside 2,3-cyclic phosphate + H2O <-> nucleoside 2-phosphate. 2,3-cyclic nucleotide 3-phosphodiesterase is a myelin-associated enzyme that makes up 4\\% of total CNS myelin protein, and is thought to undergo significant age-associated changes. The absence of CNP causes axonal swelling and neuronal degeneration. [HMDB] Inosine 2-phosphate is an inosine nucleotide containing a pyrophosphate group esterified to C2 of the sugar moiety. Inosine 2-phosphate is a product of 2,3-cyclic-nucleotide 3-phosphodiesterase (EC 3.1.4.37). This enzyme (also called CNP) catalyzes the chemical reaction: nucleoside 2,3-cyclic phosphate + H2O <-> nucleoside 2-phosphate. 2,3-cyclic nucleotide 3-phosphodiesterase is a myelin-associated enzyme that makes up 4\\% of total CNS myelin protein, and is thought to undergo significant age-associated changes. The absence of CNP causes axonal swelling and neuronal degeneration.

   

Glucose-6-phosphate lactate

({3,4,5,6-tetrahydroxy-6-[(2-hydroxypropanoyl)oxy]oxan-2-yl}methoxy)phosphonic acid

C9H17O12P (348.0458)


   

[(2R,5R)-3,4-Dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate

[(2R,5R)-3,4-Dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate

C10H13N4O8P (348.0471)


Flavour enhancer

   

Tephcalostan B

Tephcalostan B

C20H12O6 (348.0634)


   

Taiwanin C

Taiwanin C

C20H12O6 (348.0634)


A furonaphthodioxole that is furo[3,4:6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one substituted by a 1,3-benzodioxol-5-yl group at position 5. It is a naturally occurring lignan extracted from Taiwania cryptomerioides and found to be a potential inhibitor of COX2 expression.

   

Daldinone B

Daldinone B

C20H12O6 (348.0634)


   

Engelharquinone

Engelharquinone

C20H12O6 (348.0634)


   

justicidin E

justicidin E

C20H12O6 (348.0634)


   
   

Helioxanthin

Helioxanthin

C20H12O6 (348.0634)


A furonaphthodioxole that is furo[3,4:6,7]naphtho[1,2-d][1,3]dioxol-7(9H)-one substituted by a 1,3-benzodioxol-5-yl group at posiiton 10. It is a inhibitor of HBV, HCV and HSV-1 viruses.

   
   
   

Preussomerin EG1

Preussomerin EG1

C20H12O6 (348.0634)


   

2-[(4-Chlorophenyl)sulfonyl]-3-[(4,6-dimethylpyrimidin-2-yl)amino]acrylonitrile

2-[(4-Chlorophenyl)sulfonyl]-3-[(4,6-dimethylpyrimidin-2-yl)amino]acrylonitrile

C15H13ClN4O2S (348.0448)


   

3(2-Chlorophenyl)-7-hydroxy-4-phenylcoumarin

3(2-Chlorophenyl)-7-hydroxy-4-phenylcoumarin

C21H13ClO3 (348.0553)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.266 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.265 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.268

   

Altertoxin III

Altertoxin III

C20H12O6 (348.0634)


   

stemphyltoxin III

stemphyltoxin III

C20H12O6 (348.0634)


   

Chlorogensaeure

Chlorogensaeure

C16H12O9 (348.0481)


   
   

5-acetoxymethylen-2-(4-acetoxy-but-3-inyl)-dithiophene|5-acetoxymethylen-2-<4-acetoxy-but-3-inyl>-dithiophene|Di-Ac-4-[5-(Hydroxymethyl)-[2,2-bithiophen-5-yl]]-3-butyn-1-ol

5-acetoxymethylen-2-(4-acetoxy-but-3-inyl)-dithiophene|5-acetoxymethylen-2-<4-acetoxy-but-3-inyl>-dithiophene|Di-Ac-4-[5-(Hydroxymethyl)-[2,2-bithiophen-5-yl]]-3-butyn-1-ol

C17H16O4S2 (348.049)


   

palmarumycin C3

palmarumycin C3

C20H12O6 (348.0634)


   

Di-Ac-4-[5-Methyl-[2,2-bithiophen]-5-yl]-3-butyne-1,2-diol

Di-Ac-4-[5-Methyl-[2,2-bithiophen]-5-yl]-3-butyne-1,2-diol

C17H16O4S2 (348.049)


   

SCHEMBL16431152

SCHEMBL16431152

C20H12O6 (348.0634)


   
   

(8beta)-10-bromo-3-chloro-2,7-epoxychamigr-9-en-8-ol|rel-(2R,3S,5aR,9S,9aR)-7-bromo-3-chloro-2,3,4,5,9,9a-hexahydro-3,6,6,9a-tetramethyl-6H-2,5a-methano-1-benzoxepin-9-ol

(8beta)-10-bromo-3-chloro-2,7-epoxychamigr-9-en-8-ol|rel-(2R,3S,5aR,9S,9aR)-7-bromo-3-chloro-2,3,4,5,9,9a-hexahydro-3,6,6,9a-tetramethyl-6H-2,5a-methano-1-benzoxepin-9-ol

C15H22BrClO2 (348.0492)


   

Sphaerolone

Sphaerolone

C20H12O6 (348.0634)


   

Retrohelioxanthin

Retrohelioxanthin

C20H12O6 (348.0634)


   

Inosine 5-monophosphate

Inosine 5-monophosphate

C10H13N4O8P (348.0471)


   

5-Inosinic Acid

Inosine-5-monophosphate

C10H13N4O8P (348.0471)


Inosinic acid is an endogenous metabolite.

   

Inosinic acid

Polyinosinic acid

C10H13N4O8P (348.0471)


COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Inosinic acid is an endogenous metabolite.

   

Inosine-5-monophosphate

Inosine-5-monophosphate

C10H13N4O8P (348.0471)


   

Inosine 5-phosphate

Inosine 5-phosphate

C10H13N4O8P (348.0471)


   

INOSINE 5-PHOSPHATE

INOSINE 5-PHOSPHATE

C10H13N4O8P (348.0471)


   

INOSINE 5PHOSPHATE

INOSINE 5PHOSPHATE

C10H13N4O8P (348.0471)


   

INOSINE-MONOPHOSPHATE

INOSINE-MONOPHOSPHATE

C10H13N4O8P (348.0471)


   

2-IMP

Inosine 2-monophosphate

C10H13N4O8P (348.0471)


   

1,1-Binaphthyl-2,2-diyl hydrogenphosphate

1,1-Binaphthyl-2,2-diyl hydrogenphosphate

C20H13O4P (348.0551)


   

2-(5-bromo-2-pyridylazo)-5-diethylaminophenol

2-(5-bromo-2-pyridylazo)-5-diethylaminophenol

C15H17BrN4O (348.0586)


   

3-(trimethylsilyl)-2-naphthyl trifluoromethanesulfonate

3-(trimethylsilyl)-2-naphthyl trifluoromethanesulfonate

C14H15F3O3SSi (348.0463)


   

alpha-(4-Methoxybenzoyl)-2-chloro-4-nitroacetanilide

alpha-(4-Methoxybenzoyl)-2-chloro-4-nitroacetanilide

C16H13ClN2O5 (348.0513)


   

1-(trimethylsilyl)-2-naphthyl triflate

1-(trimethylsilyl)-2-naphthyl triflate

C14H15F3O3SSi (348.0463)


   

(R)-(-)-1,1-Binaphthyl-2,2-diyl hydrogenphosphate

(R)-(-)-1,1-Binaphthyl-2,2-diyl hydrogenphosphate

C20H13O4P (348.0551)


   

(S)-(+)-1,1-Binaphthyl-2,2-diyl hydrogenphosphate

(S)-(+)-1,1-Binaphthyl-2,2-diyl hydrogenphosphate

C20H13O4P (348.0551)


   

N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide hydrochloride

N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide hydrochloride

C14H18Cl2N2O2S (348.0466)


   

2-ETHOXY-5-[(MORPHOLINE-4-CARBONYL)-AMINO]-BENZENESULFONYL CHLORIDE

2-ETHOXY-5-[(MORPHOLINE-4-CARBONYL)-AMINO]-BENZENESULFONYL CHLORIDE

C13H17ClN2O5S (348.0547)


   

3-(5-Cyano-2-hydroxy-1,4-dimethyl-6-oxo-1,6-dihydropyridin-3-ylazo)benzenesulfonicacid

3-(5-Cyano-2-hydroxy-1,4-dimethyl-6-oxo-1,6-dihydropyridin-3-ylazo)benzenesulfonicacid

C14H12N4O5S (348.0528)


   

Calmodulin antagonist-1

Calmodulin antagonist-1

C14H18Cl2N2O2S (348.0466)


   

2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Glucopyranoside

2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Glucopyranoside

C12H13FN2O9 (348.0605)


   

4-Oxo-2-phenyl-4H-chromen-3-yl 2-thiophenecarboxylate

4-Oxo-2-phenyl-4H-chromen-3-yl 2-thiophenecarboxylate

C20H12O4S (348.0456)


   

6-(Trifluoromethyl)-2-pyridinemethanol 2-(4-methylbenzenesulfonate)

6-(Trifluoromethyl)-2-pyridinemethanol 2-(4-methylbenzenesulfonate)

C14H13F3NO4S (348.0517)


   

3-(heptafluoroisopropoxy)propyltrimethoxysilane

3-(heptafluoroisopropoxy)propyltrimethoxysilane

C9H15F7O4Si (348.0628)


   

5-[(6-Methoxy-1,3-benzothiazol-2-yl)amino]-3-methyl-2-thiophenecarboxylic acid ethyl ester

5-[(6-Methoxy-1,3-benzothiazol-2-yl)amino]-3-methyl-2-thiophenecarboxylic acid ethyl ester

C16H16N2O3S2 (348.0602)


   

3-(2-Chlorophenyl)-7-hydroxy-4-phenylchromen-2-one

3-(2-Chlorophenyl)-7-hydroxy-4-phenylchromen-2-one

C21H13ClO3 (348.0553)


   

(5z)-3-(4-Chlorophenyl)-4-Hydroxy-5-(1-Naphthylmethylene)furan-2(5h)-One

(5z)-3-(4-Chlorophenyl)-4-Hydroxy-5-(1-Naphthylmethylene)furan-2(5h)-One

C21H13ClO3 (348.0553)


   

2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Mannopyranoside

2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Mannopyranoside

C12H13FN2O9 (348.0605)


   

N7-(5-Phospho-alpha-ribosyl)-2-hydroxypurine

N7-(5-Phospho-alpha-ribosyl)-2-hydroxypurine

C10H13N4O8P (348.0471)


   
   

2,4-DINITROPHENYL-2-FLUORO-2-DEOXY-BETA-D-GLUCOPYRANOSIDE

2,4-DINITROPHENYL-2-FLUORO-2-DEOXY-BETA-D-GLUCOPYRANOSIDE

C12H13FN2O9 (348.0605)


   

3-deoxy-D-glycero-beta-D-galacto-nonulosonic acid 9-phosphate

3-deoxy-D-glycero-beta-D-galacto-nonulosonic acid 9-phosphate

C9H17O12P (348.0458)


A ketoaldonic acid phosphate that is 3-deoxy-D-glycero-beta-D-galacto-nonulosonic acid carrying a monophosohate substituent at position 9.

   

[5-(2,6-dioxo-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate

[5-(2,6-dioxo-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate

C10H13N4O8P (348.0471)


   

(2R)-3-phosphonooxy-2-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropanoic acid

(2R)-3-phosphonooxy-2-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropanoic acid

C9H17O12P (348.0458)


   

Inosine 2-phosphate

Inosine 2-phosphate

C10H13N4O8P (348.0471)


   

[2,3,4,5-Tetrahydroxy-6-(phosphonooxymethyl)oxan-2-yl] 2-hydroxypropanoate

[2,3,4,5-Tetrahydroxy-6-(phosphonooxymethyl)oxan-2-yl] 2-hydroxypropanoate

C9H17O12P (348.0458)


   

Aflatoxin B1 dialdehyde

Aflatoxin B1 dialdehyde

C16H12O9 (348.0481)


   

4-Chloro-3-[[(2-methyl-3-nitrophenyl)-oxomethyl]amino]benzoic acid methyl ester

4-Chloro-3-[[(2-methyl-3-nitrophenyl)-oxomethyl]amino]benzoic acid methyl ester

C16H13ClN2O5 (348.0513)


   

N-(1,3-dioxo-2-phenyl-5-isoindolyl)-2-thiophenecarboxamide

N-(1,3-dioxo-2-phenyl-5-isoindolyl)-2-thiophenecarboxamide

C19H12N2O3S (348.0569)


   

Inosine 3-monophosphate

Inosine 3-monophosphate

C10H13N4O8P (348.0471)


   

4-chloro-3-nitrobenzaldehyde N-(4-methylphenyl)thiosemicarbazone

4-chloro-3-nitrobenzaldehyde N-(4-methylphenyl)thiosemicarbazone

C15H13ClN4O2S (348.0448)


   

N-[1-[(2-bromophenyl)methyl]-2-oxo-3-pyridinyl]butanamide

N-[1-[(2-bromophenyl)methyl]-2-oxo-3-pyridinyl]butanamide

C16H17BrN2O2 (348.0473)


   

2-[(5-amino-7-methyl-[1,2,4]triazolo[4,3-c]pyrimidin-3-yl)thio]-N-(4-chlorophenyl)acetamide

2-[(5-amino-7-methyl-[1,2,4]triazolo[4,3-c]pyrimidin-3-yl)thio]-N-(4-chlorophenyl)acetamide

C14H13ClN6OS (348.056)


   

2-(alpha-D-mannosyl)-3-phosphoglyceric acid

2-(alpha-D-mannosyl)-3-phosphoglyceric acid

C9H17O12P (348.0458)


   

2-(2,5-Dihydroxy-4-methoxyphenyl)-3,5,6,7-tetrahydroxychromen-4-one

2-(2,5-Dihydroxy-4-methoxyphenyl)-3,5,6,7-tetrahydroxychromen-4-one

C16H12O9 (348.0481)


   

Diphenyldi(3-thienyl)silane

Diphenyldi(3-thienyl)silane

C20H16S2Si (348.0463)


   

2-O-(6-Phospho-alpha-mannosyl)-D-glycerate

2-O-(6-Phospho-alpha-D-mannosyl)-D-glycerate

C9H17O12P (348.0458)


   

IMP

IMP

C10H13N4O8P (348.0471)


A purine ribonucleoside 5-monophosphate having hypoxanthine as the nucleobase.

   

(1r,5r,6s)-3-bromo-9-chloro-2,2,6,9-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodec-3-en-5-ol

(1r,5r,6s)-3-bromo-9-chloro-2,2,6,9-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodec-3-en-5-ol

C15H22BrClO2 (348.0492)


   

1,6,8c-trihydroxy-7ah,8ah,8bh-peryleno[1,2-b]oxirene-7,11-dione

1,6,8c-trihydroxy-7ah,8ah,8bh-peryleno[1,2-b]oxirene-7,11-dione

C20H12O6 (348.0634)


   

7,13,17-trihydroxy-12-oxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁶,²¹]henicosa-1,3,5,7,10,16,18,20-octaene-9,15-dione

7,13,17-trihydroxy-12-oxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁶,²¹]henicosa-1,3,5,7,10,16,18,20-octaene-9,15-dione

C20H12O6 (348.0634)


   

(1s,2r,2'r,4s,4's,5's,6r)-5'-bromo-4'-chloro-1,4,4'-trimethyl-3-methylidene-7-oxaspiro[bicyclo[4.1.0]heptane-2,1'-cyclohexan]-2'-ol

(1s,2r,2'r,4s,4's,5's,6r)-5'-bromo-4'-chloro-1,4,4'-trimethyl-3-methylidene-7-oxaspiro[bicyclo[4.1.0]heptane-2,1'-cyclohexan]-2'-ol

C15H22BrClO2 (348.0492)


   

(4s,6s,8r)-8,10,16,18-tetrahydroxy-5-oxahexacyclo[11.7.1.0²,¹².0³,⁹.0⁴,⁶.0¹⁷,²¹]henicosa-1(21),2,9,11,13,15,17,19-octaen-7-one

(4s,6s,8r)-8,10,16,18-tetrahydroxy-5-oxahexacyclo[11.7.1.0²,¹².0³,⁹.0⁴,⁶.0¹⁷,²¹]henicosa-1(21),2,9,11,13,15,17,19-octaen-7-one

C20H12O6 (348.0634)


   

(8bs,8cr)-1,6,8c-trihydroxy-7ah,8ah,8bh-peryleno[1,2-b]oxirene-7,11-dione

(8bs,8cr)-1,6,8c-trihydroxy-7ah,8ah,8bh-peryleno[1,2-b]oxirene-7,11-dione

C20H12O6 (348.0634)


   

5'-bromo-4'-chloro-1,4,4'-trimethyl-3-methylidene-7-oxaspiro[bicyclo[4.1.0]heptane-2,1'-cyclohexan]-2'-ol

5'-bromo-4'-chloro-1,4,4'-trimethyl-3-methylidene-7-oxaspiro[bicyclo[4.1.0]heptane-2,1'-cyclohexan]-2'-ol

C15H22BrClO2 (348.0492)


   

8,10,16,18-tetrahydroxy-5-oxahexacyclo[11.7.1.0²,¹².0³,⁹.0⁴,⁶.0¹⁷,²¹]henicosa-1(20),2,9,11,13(21),14,16,18-octaen-7-one

8,10,16,18-tetrahydroxy-5-oxahexacyclo[11.7.1.0²,¹².0³,⁹.0⁴,⁶.0¹⁷,²¹]henicosa-1(20),2,9,11,13(21),14,16,18-octaen-7-one

C20H12O6 (348.0634)


   

(7ar,8ar,8bs,8cr)-1,6,8c-trihydroxy-7ah,8ah,8bh-peryleno[1,2-b]oxirene-7,11-dione

(7ar,8ar,8bs,8cr)-1,6,8c-trihydroxy-7ah,8ah,8bh-peryleno[1,2-b]oxirene-7,11-dione

C20H12O6 (348.0634)


   

3,6-dihydroxy-1a,7a-dihydro-2',4'-dioxaspiro[naphtho[2,3-b]oxirene-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-7-one

3,6-dihydroxy-1a,7a-dihydro-2',4'-dioxaspiro[naphtho[2,3-b]oxirene-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-7-one

C20H12O6 (348.0634)


   

5,7'-dihydroxy-2',11'-dioxaspiro[naphthalene-1,3'-tetracyclo[6.4.1.0⁴,¹³.0¹⁰,¹²]tridecane]-4'(13'),5',7'-triene-4,9'-dione

5,7'-dihydroxy-2',11'-dioxaspiro[naphthalene-1,3'-tetracyclo[6.4.1.0⁴,¹³.0¹⁰,¹²]tridecane]-4'(13'),5',7'-triene-4,9'-dione

C20H12O6 (348.0634)


   

(1r,5s,6r,8r,9s)-3-bromo-9-chloro-2,2,6,9-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodec-3-en-5-ol

(1r,5s,6r,8r,9s)-3-bromo-9-chloro-2,2,6,9-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodec-3-en-5-ol

C15H22BrClO2 (348.0492)


   

3-bromo-9-chloro-2,2,6,9-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodec-3-en-5-ol

3-bromo-9-chloro-2,2,6,9-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodec-3-en-5-ol

C15H22BrClO2 (348.0492)


   

(1s,3s,4r,6s,8s,9r)-3-bromo-4-chloro-4,12,12-trimethyl-11-methylidene-7-oxatricyclo[6.3.1.0¹,⁶]dodecan-9-ol

(1s,3s,4r,6s,8s,9r)-3-bromo-4-chloro-4,12,12-trimethyl-11-methylidene-7-oxatricyclo[6.3.1.0¹,⁶]dodecan-9-ol

C15H22BrClO2 (348.0492)


   

3-bromo-4-chloro-4,12,13,13-tetramethyl-7,11-dioxatetracyclo[6.4.1.0¹,⁶.0¹⁰,¹²]tridecane

3-bromo-4-chloro-4,12,13,13-tetramethyl-7,11-dioxatetracyclo[6.4.1.0¹,⁶.0¹⁰,¹²]tridecane

C15H22BrClO2 (348.0492)


   

16-(2h-1,3-benzodioxol-5-yl)-3,5,13-trioxatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1,6,8,10,15-pentaen-14-one

16-(2h-1,3-benzodioxol-5-yl)-3,5,13-trioxatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1,6,8,10,15-pentaen-14-one

C20H12O6 (348.0634)


   

8,12,17-trihydroxypentacyclo[10.7.1.0²,¹¹.0⁴,⁹.0¹³,¹⁸]icosa-2(11),4,6,8,13,15,17-heptaene-3,10,19-trione

8,12,17-trihydroxypentacyclo[10.7.1.0²,¹¹.0⁴,⁹.0¹³,¹⁸]icosa-2(11),4,6,8,13,15,17-heptaene-3,10,19-trione

C20H12O6 (348.0634)


   

(13r)-7,13,17-trihydroxy-12-oxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁶,²¹]henicosa-1,3,5,7,10,16,18,20-octaene-9,15-dione

(13r)-7,13,17-trihydroxy-12-oxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁶,²¹]henicosa-1,3,5,7,10,16,18,20-octaene-9,15-dione

C20H12O6 (348.0634)


   

3-bromo-4-chloro-4,11,12,12-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodecan-10-one

3-bromo-4-chloro-4,11,12,12-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodecan-10-one

C15H22BrClO2 (348.0492)


   

(1as,7ar)-3,6-dihydroxy-1a,7a-dihydro-2',4'-dioxaspiro[naphtho[2,3-b]oxirene-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-7-one

(1as,7ar)-3,6-dihydroxy-1a,7a-dihydro-2',4'-dioxaspiro[naphtho[2,3-b]oxirene-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-7-one

C20H12O6 (348.0634)


   

(1r,1'r,10'r,12'r)-5,7'-dihydroxy-2',11'-dioxaspiro[naphthalene-1,3'-tetracyclo[6.4.1.0⁴,¹³.0¹⁰,¹²]tridecane]-4'(13'),5',7'-triene-4,9'-dione

(1r,1'r,10'r,12'r)-5,7'-dihydroxy-2',11'-dioxaspiro[naphthalene-1,3'-tetracyclo[6.4.1.0⁴,¹³.0¹⁰,¹²]tridecane]-4'(13'),5',7'-triene-4,9'-dione

C20H12O6 (348.0634)


   

(3r,3'r,4's)-3'-bromo-1-chloro-2',2',6-trimethyl-6'-methylidene-7-oxaspiro[bicyclo[4.1.0]heptane-3,1'-cyclohexan]-4'-ol

(3r,3'r,4's)-3'-bromo-1-chloro-2',2',6-trimethyl-6'-methylidene-7-oxaspiro[bicyclo[4.1.0]heptane-3,1'-cyclohexan]-4'-ol

C15H22BrClO2 (348.0492)


   

3,4,7,8-tetrahydroxy-10h,11h-cyclohexa[j]fluoranthene-9,12-dione

3,4,7,8-tetrahydroxy-10h,11h-cyclohexa[j]fluoranthene-9,12-dione

C20H12O6 (348.0634)


   

2-amino-5-(5-carboxy-6-hydroxy-4-imino-3-oxocyclohexa-1,5-dien-1-yl)-6-hydroxy-3-methoxybenzoic acid

2-amino-5-(5-carboxy-6-hydroxy-4-imino-3-oxocyclohexa-1,5-dien-1-yl)-6-hydroxy-3-methoxybenzoic acid

C15H12N2O8 (348.0594)


   

(2s,3r,5r,12s,13r,15r)-8,18-dihydroxy-4,14-dioxaheptacyclo[10.8.1.1²,⁷.0³,⁵.0¹³,¹⁵.0¹⁷,²¹.0¹¹,²²]docosa-1(21),7(22),8,10,17,19-hexaene-6,16-dione

(2s,3r,5r,12s,13r,15r)-8,18-dihydroxy-4,14-dioxaheptacyclo[10.8.1.1²,⁷.0³,⁵.0¹³,¹⁵.0¹⁷,²¹.0¹¹,²²]docosa-1(21),7(22),8,10,17,19-hexaene-6,16-dione

C20H12O6 (348.0634)


   

(6s)-6-ethenyl-7,11,17,19,23-pentaoxahexacyclo[11.10.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁶,²⁰]tricosa-1(13),2(10),3,8,14(22),15,20-heptaen-12-one

(6s)-6-ethenyl-7,11,17,19,23-pentaoxahexacyclo[11.10.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁶,²⁰]tricosa-1(13),2(10),3,8,14(22),15,20-heptaen-12-one

C20H12O6 (348.0634)


   

(1r,3s,4s,6r,8s,11r)-3-bromo-4-chloro-4,11,12,12-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodecan-10-one

(1r,3s,4s,6r,8s,11r)-3-bromo-4-chloro-4,11,12,12-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodecan-10-one

C15H22BrClO2 (348.0492)


   

(1r,5r,6r,8r,9s)-3-bromo-9-chloro-2,2,6,9-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodec-3-en-5-ol

(1r,5r,6r,8r,9s)-3-bromo-9-chloro-2,2,6,9-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodec-3-en-5-ol

C15H22BrClO2 (348.0492)


   

(4r,6r,8s)-8,10,16,18-tetrahydroxy-5-oxahexacyclo[11.7.1.0²,¹².0³,⁹.0⁴,⁶.0¹⁷,²¹]henicosa-1(20),2,9,11,13(21),14,16,18-octaen-7-one

(4r,6r,8s)-8,10,16,18-tetrahydroxy-5-oxahexacyclo[11.7.1.0²,¹².0³,⁹.0⁴,⁶.0¹⁷,²¹]henicosa-1(20),2,9,11,13(21),14,16,18-octaen-7-one

C20H12O6 (348.0634)


   

(1r,2r,2'r,4r,4's,5's,6s)-5'-bromo-4'-chloro-1,4,4'-trimethyl-3-methylidene-7-oxaspiro[bicyclo[4.1.0]heptane-2,1'-cyclohexan]-2'-ol

(1r,2r,2'r,4r,4's,5's,6s)-5'-bromo-4'-chloro-1,4,4'-trimethyl-3-methylidene-7-oxaspiro[bicyclo[4.1.0]heptane-2,1'-cyclohexan]-2'-ol

C15H22BrClO2 (348.0492)


   

2-amino-5-(4-amino-5-carboxy-3,6-dioxocyclohexa-1,4-dien-1-yl)-6-hydroxy-3-methoxybenzoic acid

2-amino-5-(4-amino-5-carboxy-3,6-dioxocyclohexa-1,4-dien-1-yl)-6-hydroxy-3-methoxybenzoic acid

C15H12N2O8 (348.0594)


   

(1r,12s)-8,12,17-trihydroxypentacyclo[10.7.1.0²,¹¹.0⁴,⁹.0¹³,¹⁸]icosa-2(11),4,6,8,13,15,17-heptaene-3,10,19-trione

(1r,12s)-8,12,17-trihydroxypentacyclo[10.7.1.0²,¹¹.0⁴,⁹.0¹³,¹⁸]icosa-2(11),4,6,8,13,15,17-heptaene-3,10,19-trione

C20H12O6 (348.0634)


   

16-(2h-1,3-benzodioxol-5-yl)-3,5,13-trioxatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1,6,8,10,15-pentaen-12-one

16-(2h-1,3-benzodioxol-5-yl)-3,5,13-trioxatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1,6,8,10,15-pentaen-12-one

C20H12O6 (348.0634)


   

8,18-dihydroxy-4,14-dioxaheptacyclo[10.8.1.1²,⁷.0³,⁵.0¹³,¹⁵.0¹⁷,²¹.0¹¹,²²]docosa-1(21),7(22),8,10,17,19-hexaene-6,16-dione

8,18-dihydroxy-4,14-dioxaheptacyclo[10.8.1.1²,⁷.0³,⁵.0¹³,¹⁵.0¹⁷,²¹.0¹¹,²²]docosa-1(21),7(22),8,10,17,19-hexaene-6,16-dione

C20H12O6 (348.0634)


   

3-bromo-4-chloro-4,12,12-trimethyl-11-methylidene-7-oxatricyclo[6.3.1.0¹,⁶]dodecan-9-ol

3-bromo-4-chloro-4,12,12-trimethyl-11-methylidene-7-oxatricyclo[6.3.1.0¹,⁶]dodecan-9-ol

C15H22BrClO2 (348.0492)


   

(1r,3s,4s,6r,8s,10s,12r)-3-bromo-4-chloro-4,12,13,13-tetramethyl-7,11-dioxatetracyclo[6.4.1.0¹,⁶.0¹⁰,¹²]tridecane

(1r,3s,4s,6r,8s,10s,12r)-3-bromo-4-chloro-4,12,13,13-tetramethyl-7,11-dioxatetracyclo[6.4.1.0¹,⁶.0¹⁰,¹²]tridecane

C15H22BrClO2 (348.0492)


   

(2s)-2-[(1r,3r,4r)-3-bromo-4-chloro-4-methylcyclohexyl]-2,6,6-trimethylpyran-3-one

(2s)-2-[(1r,3r,4r)-3-bromo-4-chloro-4-methylcyclohexyl]-2,6,6-trimethylpyran-3-one

C15H22BrClO2 (348.0492)


   

4-{5'-[(acetyloxy)methyl]-[2,2'-bithiophen]-5-yl}but-3-yn-1-yl acetate

4-{5'-[(acetyloxy)methyl]-[2,2'-bithiophen]-5-yl}but-3-yn-1-yl acetate

C17H16O4S2 (348.049)


   

2-(3-bromo-4-chloro-4-methylcyclohexyl)-2,6,6-trimethylpyran-3-one

2-(3-bromo-4-chloro-4-methylcyclohexyl)-2,6,6-trimethylpyran-3-one

C15H22BrClO2 (348.0492)


   

16-hydroxy-2,12,21-trioxahexacyclo[9.9.1.1¹,¹³.1³,⁷.0¹¹,²³.0¹⁷,²²]tricosa-3,5,7(23),9,13,15,17(22)-heptaene-8,18-dione

16-hydroxy-2,12,21-trioxahexacyclo[9.9.1.1¹,¹³.1³,⁷.0¹¹,²³.0¹⁷,²²]tricosa-3,5,7(23),9,13,15,17(22)-heptaene-8,18-dione

C20H12O6 (348.0634)


   

(2r)-2-[(1s,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-2,6,6-trimethylpyran-3-one

(2r)-2-[(1s,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-2,6,6-trimethylpyran-3-one

C15H22BrClO2 (348.0492)


   

(1r,5r)-3-bromo-9-chloro-2,2,6,9-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodec-3-en-5-ol

(1r,5r)-3-bromo-9-chloro-2,2,6,9-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodec-3-en-5-ol

C15H22BrClO2 (348.0492)


   

3,7,8,9-tetrahydroxy-10h,11h-cyclohexa[j]fluoranthene-4,12-dione

3,7,8,9-tetrahydroxy-10h,11h-cyclohexa[j]fluoranthene-4,12-dione

C20H12O6 (348.0634)